Downregulation of interleukin-12 (IL-12) responsiveness in human T cells by transforming growth factor-β: Relationship with IL-12 signaling

Blood

Volumn 93, Issue 5, 1999, Pages 1448-1455

  Pardoux, Cécile ^b   Ma, Xiaojing ^b   Gobert, Stéphanie ^b   Pellegrini, Sandra ^b   Mayeux, Patrick ^b   Gay, Françoise ^b   Trinchieri, Giorgio ^b   Chouaib, Salem ^a  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; RECEPTOR SUBUNIT; RECOMBINANT INTERLEUKIN 12; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; STAT4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELLULAR IMMUNITY; CYTOTOXICITY; DNA BINDING; DOWN REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0033104705     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.5.1448.403k36_1448_1455     Document Type: Article

References (58)

1. Chehimi J, Trinchieri G: Interleukin-12: A bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J Clin Immunol 14:149, 1994
2. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G: Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170:827, 1989
3. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, Trinchieri G: Induction of IFN gamma production by NK cell stimulatory factor (NKSF): Characterization of the responder cells and synergy with other inducers. J Exp Med 173:869, 1991
4. Perussia B, Chan SH, D'Andrea A, Tsuji K, Santoli D, Pospisil M, Young D, Wolf SF, Trinchieri G: Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR αβ+, TCR γδ+ T lymphocytes, and NK cells. J Immunol 149:3495, 1992
5. Valiante NM, Rengaraju M, Trinchieri G: Role of the production of natural killer cell stimulatory factor (NKSF/IL-12) in the ability of B cell lines to stimulate T and NK cell proliferation. Cell Immunol 145:187, 1992
6. Naume B, Johnsen AC, Espevik T, Sundan A: Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56+ natural killer cells stimulated with interleukin-2, interleukin-7 and interleukin-12. Eur J Immunol 23:1831, 1993
7. Aste-Amezaga M, D'Andrea A, Kubin M, Trinchieri G: Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell Immunol 156:480, 1994
8. Robertson MJ, Soiffer RJ, Wolf SF, Manley TJ, Donahue C, Young D, Herrmann SH, Ritz J: Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): Cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med 175:779, 1992
9. Chehimi J, Starr SE, Frank I, Rengaraju M, Jackson J, Llanes C, Kobayashi M, Perussia B, Young D, Nickbarg E, Wolf SF, Trinchieri G: Natural killer cell stimulatory factor (NKSF) increases the cytotoxic activity of NK cells from both healthy donors and HIV-infected patients. J Exp Med 175:789, 1992
10. Naume B, Gately M, Espevik T: A comparative study of IL-12 (cytotoxic maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells. J Immunol 148:2429, 1992
11. Chehimi J, Valiante NM, D'Andrea A, Rengaraju M, Rosado Z, Kobayashi M, Perussia B, Wolf SF, Starr SE, Trinchieri G: Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells. Eur J Immunol 23:1826, 1993
12. Gately MK, Wolitzky AG, Quinn PM, Chizzonite R: Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell Immunol 143:127, 1992
13. Mehrotra PT, Wu D, Crim JA, Mostowski HS, Siegel JP: Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes. J Immunol 151:2444, 1993
14. Trinchieri G: Interleukin-12 and its role in the generation of Th1 cells. Immunol Today 14:335, 1993
15. Manetti R, Parronchi P, Giudizi MG, Piccini MP, Maggi E, Trinchieri G, Romagnani S: Natural killer cell stimulatory factor (interleukin-12 [IL-12]) induces (Th1)-type specific immune responses and inhibits the development of IL-4 producing Th2 cells. J Exp Med 177:1199, 1993
16. Clerici M, Lucev DR, Berzofsky JA, Pinto LA, Wynn TA, Blatt SP, Dolan MJ, Hendrix CW, Wolf SF, Shearer GM: Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 262:1721, 1993
17. Chehimi J, Starr SE, Franck I, D'Andrea A, Ma X, MacGregor RR, Sennelier J, Trinchieri G: Impaired interleukin-12 production in human immunodeficiency virus-infected patients. J Exp Med 179:1361, 1994
18. Desai BB, Quinn PM, Mongini A, Chizzonite R, Gately MK: The IL-12 receptor. II. Distribution and regulation of receptor expression. J Immunol 148:3125, 1992
19. Wu C, Warrier R, Carvajal D, Chua A, Minetti L, Chizzonite R, Mongini P, Stern A, Gubler U, Presky D, Gately M: Biological function and distribution of human interleukin-12 receptor β chain. Eur J Immunol 26:345, 1996
20. Chizzonite R, Truitt T, Desai BB, Nunes P, Podlaski FJ, Stern AS, Gately MK: IL-12 receptor. I. Characterization of the receptor on phytohemagglutin-activated human lymphoblasts. J Immunol 148: 3117, 1992
21. Chua AO, Chizzonite R, Desai B: Expression cloning of a human IL-12 receptor component: A new member of the cytokine receptor superfamily with strong homology with gp130. J Immunol 153:128, 1994
22. Wu C, Warrier R, Wang X, Presky D, Gately M: Characterization of IL-12 receptor beta1 chain (IL-12Rbeta1)-deficient mice: IL-12R beta1 is an essential component of the functional mouse IL-12 receptor. Eur J Immunol 27:147, 1997
23. Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, Gately MK, Gubler U: A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci USA 93:14002, 1996
24. Bacon C, McVicar DW, Ortaldo JR, Rees RC, O'Shea JJ, Johnston JA: Interleukin-12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: Differential use of janus family tyrosine kinases by IL-2 and IL-12. J Exp Med 181:399, 1995
25. Zou J, Presky D, Wu C, Gubler U: Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits β1 and β2 and JAK kinases. J Biol Chem 272:6073, 1997
26. Pellegrini S, Dusanter-Fourt I: The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs). Eur J Biochem 248:615, 1997
27. Bacon CM, Petricoin EF, Ortaldo JR, Rees RC, Lamer AC, Johnston JA, O'Shea JJ: Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc Natl Acad Sci USA 92:7307, 1995
28. Cho SS, Bacon CM, Sudarshan C, Rees RC, Finbloom D, Pine R, O'Shea JJ: Activation of STAT4 by IL-12 and IFN-α: Evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. J Immunol 157:4781, 1996
29. Moses HL, Yang EY, Pietenpol JA: TGF-beta stimulation and inhibition of cell proliferation: New mechanistic insights (minireview). Cell 63:245, 1990
30. Espevik T, Figari IS, Shalaby MR, Lackides GA, Lewis GD, Shepard HM, Palladino MA Jr: Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J Exp Med 166:571, 1987
31. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB, Fauci AS: Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163:1037, 1986
32. Ranges GE, Figari IS, Espevik T, Palladino MA Jr: Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. J Exp Med 166:991, 1987
33. Fontana A, Hengartner H, Tribolet ND, Weber E: Glioblastoma cells release interleukin-1 and factors inhibiting interleukin-2 mediated effects. J Immunol 132:1837, 1984
34. Ruegemer JJ, Ho SN, Augustine JA, Schlager JW, Bell MP, Kean DJM, Abraham RT: Regulatory effects of transforming growth factor-beta on IL-2 and IL-4 dependent T cell-cycle progression. J Immunol 144:1767, 1990
35. Su HC, Leite-Morris KA, Braun L, Biron CA: A role for transforming growth factor-β1 in regulating natural killer and T cell lymphocyte proliferative response during acute infection with lymphocyte choriomeningitis virus. J Immunol 147:2717, 1991
36. Pardoux C, Asselin-Paturel C, Chehimi J, Gay F, Mami-Chouaib F, Chouaib S: Functional interaction between transforming growth factor beta and IL-12 in human primary allogeneic cytotoxicity and proliferative response. J Immunol 158:136, 1997
37. Barbieri G, Velazquez L, Scrobogna M, Fellous M, Pellegrini S: Activation of the protein tyrosine kinase tyk2 by interferon alpha/beta. Eur J Biochem 223:427, 1994
38. Chouaib S, Bertoglio J, Blay J, Marchiol C, Fradelizi D: Lymphokine-activated killer generation pathways: Synergy between Tumor Necrosis Factor and Interleukin-2. Proc Natl Acad Sci USA 85:6875, 1988
39. Gobert S, Chretien S, Gouilleux F, Muller O, Pallard C, Dusanter-Fourt I, Groner B, Lacombe C, Gisselbrecht S, Mayeux P: Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STATS activation. EMBO J 15:2434, 1996
40. Pearse R, Feinman R, Ravetch J: Characterization of the promoter of the human gene encoding the high-affinity IgG receptor: Transcriptional induction by gamma-interferon is mediated through common DNA response elements. Proc Natl Acad Sci USA 88:11305, 1991
41. Ihle J, Witthuhn B, Quelle F, Yamamoto K, Silvennoinen O: Signaling through the hematopoietic cytokine receptors. Annu Rev Immunol 13:369, 1995
42. Thierfelder E, Deursen JV, Yamamoto K, Tripp R, Sarawar S, Carson R, Sangster M, Vignali D, Doherty P, Grosveld G. Ihle J: Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382:171, 1996
43. Kaplan M, Sun Y, Hoey T, Grusby M: Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174, 1996
44. Lamer A, David M, Feldman G, Igarashi K, Hackett R, Webb D, Sweitzer S, Petricoin Ed, Finbloom D: Tyrosine phosphorylation of DNA binding proteins by multiple cytokines. Science 261:1730, 1993
45. Trinchieri G: Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008, 1994
46. Güler M, Jacobson N, Gubler U, Murphy K: T cell genetic background determines maintenance of IL-12 signaling. Effects on BALB/c and B10.D2 T helper cell type 1 phenotype development. J Immunol 159:1767, 1997
47. Szabo SJ, Jacobson NG, Dighe AS, Gubler U, Murphy KM: Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2:665, 1995
48. Szabo S, Dighe A, Gubler U, Murphy K: Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med 1997 185:817, 1997
49. Rogge L, Barberis-Maino L, Biffi M, Passini N, Presky D, Gubler U, Sinigaglia F: Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 185:825, 1997
50. Wu C, Warrier R, Wang X, Presky D, Gately M: Regulation of interleukin-12 receptor β1 chain expression and interleukin-12 binding by human peripheral blood mononuclear cells. Eur J Immunol 27:147, 1997
51. Hilkens C, Messer G, Tesselaar K, Rietschoten Av, Kapsenberg M, Wierenga E: Lack of IL-12 signaling in human allergen-specific Th2 cells. J Immunol 157:4316, 1996
52. Barbulescu K, Becker C, Schlaak J, Schmitt E, Buschenfelde KMZ, Neurath M: IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes. J Immunol 1998 160:3642, 1998
53. Bright J, Kerr L, Sriram S: TGF-b inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat5 in T lymphocytes. J Immunol 159:175, 1997
54. Pazdrak K, Justement L, Alam R: Mechanism of inhibition of eosinophil activation by transforming growth factor-beta. Inhibition of Lyn, MAP, Jak2 kinases and STAT1 nuclear factor. J Immunol 155:4454, 1995
55. Gruppuso P, Mikumo R, Brautigan D, Braun L: Growth arrest induced by transforming growth factor beta 1 is accompanied by protein phosphatase activation in human keratinocytes. J Biol Chem 266:3444, 1991
56. Piskurich J, Wang Y, Linhoff M, White L, Ting JPY: Identification of distinct regions of 5′ flanking DNA that mediate constitutive, IFN-γ, STAT1, and TGF-β-regulated expression of the class II transactivator gene. J Immunol 160:233, 1998
57. Chouaib S, Asselin-Paturel C, Caignard A, Mami-Chouaib F, Blay JY: The tumor-host immune system conflict: From tolerance and resistance to destruction. Immunol Today 18:493, 1997
58. Maeda H, Shiraishi A: TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10 mediated pathways in tumor-bearing mice. J Immunol 156:73, 1996